{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:59:51Z","timestamp":1789610391750,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.intimp.2014.05.027","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T13:40:39Z","timestamp":1401716439000},"page":"342-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Diminazene aceturate (Berenil), a new use for an old compound?"],"prefix":"10.1016","volume":"21","author":[{"given":"Shiby","family":"Kuriakose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude E.","family":"Uzonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\u20134","key":"10.1016\/j.intimp.2014.05.027_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0001-706X(93)90092-P","article-title":"Pharmacology of diminazene: a review","volume":"54","author":"Peregrine","year":"1993","journal-title":"Acta Trop"},{"issue":"11","key":"10.1016\/j.intimp.2014.05.027_bb0010","first-page":"634","article-title":"4, 4\u2032-Diamidino-diazoaminobenzene, a new agent in the treatment of trypanosomiasis and babesiasis","volume":"5","author":"Jensch","year":"1955","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"10.1016\/j.intimp.2014.05.027_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0162-0134(97)00111-6","article-title":"The berenil ligand directs the DNA binding of the cytotoxic drug Pt-berenil","volume":"68","author":"Gonzalez","year":"1997","journal-title":"J Inorg Biochem"},{"issue":"1","key":"10.1016\/j.intimp.2014.05.027_bb0020","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-291X(80)91221-8","article-title":"Berenil induces the complete loss of kinetoblast DNA sequences in Trypanosoma equiperdum","volume":"96","author":"Riou","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.027_bb0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0022-5320(72)90122-0","article-title":"Molecular organization of the kinetoplast DNA of Trypanosoma cruzi treated with berenil, a DNA interacting drug","volume":"39","author":"Brack","year":"1972","journal-title":"J Ultrastruct Res"},{"issue":"1","key":"10.1016\/j.intimp.2014.05.027_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000132713","article-title":"Berenil-induced undercondensation in human heterochromatin","volume":"50","author":"Haaf","year":"1989","journal-title":"Cytogenet Cell Genet"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1247\/csf.15.151","article-title":"The minor-groove binding DNA-ligands netropsin, distamycin A and berenil cause polyploidisation via impairment of the G2 phase of the cell cycle","volume":"15","author":"Poot","year":"1990","journal-title":"Cell Struct Funct"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0040","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/IAI.26.3.822-826.1979","article-title":"Suppression of antibody response to Leptospira biflexa and Brucella abortus and recovery from immunosuppression after Berenil treatment","volume":"26","author":"Rurangirwa","year":"1979","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.intimp.2014.05.027_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-3024.1999.00202.x","article-title":"Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance","volume":"21","author":"Uzonna","year":"1999","journal-title":"Parasite Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.027_bb0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2307\/3282517","article-title":"Enhanced resistance of highly susceptible Balb\/c mice to infection with Trypanosoma congolense after infection and cure","volume":"73","author":"Otesile","year":"1987","journal-title":"J Parasitol"},{"issue":"2","key":"10.1016\/j.intimp.2014.05.027_bb0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0035-9203(81)90341-2","article-title":"The interaction of Berenil with histamine on isolated mammalian tissues","volume":"75","author":"Arowolo","year":"1981","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.intimp.2014.05.027_bb0060","first-page":"199","article-title":"Studies in cattle on the disposition of the anti-trypanosomal drug diminazene diaceturate (Berenil)","volume":"36","author":"Kellner","year":"1985","journal-title":"Trop Med Parasitol"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00142049","article-title":"The influence of Trypanosoma congolense infection on the disposition kinetics of diminazene aceturate in the dog","volume":"13","author":"Onyeyili","year":"1989","journal-title":"Vet Res Commun"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.027_bb0070","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1128\/AAC.37.5.1050","article-title":"Comparative pharmacokinetics of diminazene in noninfected Boran (Bos indicus) cattle and Boran cattle infected with Trypanosoma congolense","volume":"37","author":"Mamman","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2885.1993.tb00176.x","article-title":"Pharmacokinetics of diminazene in female Boran (Bos indicus) cattle","volume":"16","author":"Aliu","year":"1993","journal-title":"J Vet Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.intimp.2014.05.027_bb0080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/AAC.39.5.1107","article-title":"Frequency of diminazene-resistant trypanosomes in populations of Trypanosoma congolense arising in infected animals following treatment with diminazene aceturate","volume":"39","author":"Mamman","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.intimp.2014.05.027_bb0085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1087057111413919","article-title":"Prediction of off-target effects on angiotensin-converting enzyme 2","volume":"16","author":"Kulemina","year":"2011","journal-title":"J Biomol Screen"},{"issue":"6","key":"10.1016\/j.intimp.2014.05.027_bb0090","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1164\/rccm.201205-0880OC","article-title":"Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models","volume":"187","author":"Shenoy","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.intimp.2014.05.027_bb0095","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","article-title":"Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke","volume":"96","author":"Mecca","year":"2011","journal-title":"Exp Physiol"},{"issue":"6","key":"10.1016\/j.intimp.2014.05.027_bb0100","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1167\/iovs.12-11427","article-title":"Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2","volume":"54","author":"Foureaux","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.intimp.2014.05.027_bb0105","doi-asserted-by":"crossref","first-page":"e48696","DOI":"10.1371\/journal.pone.0048696","article-title":"Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection","volume":"7","author":"Kuriakose","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2014.05.027_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2008.00675.x","article-title":"T cells and immunopathogenesis of experimental African trypanosomiasis","volume":"225","author":"Tabel","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2014.05.027_bb0115","doi-asserted-by":"crossref","DOI":"10.1177\/1753425913507488","article-title":"Diminazene aceturate (Berenil) modulates LPS induced proinflammatory cytokine production by inhibiting phosphorylation of MAPKs and STAT proteins","author":"Kuriakose","year":"2013","journal-title":"Innate Immun"},{"issue":"1","key":"10.1016\/j.intimp.2014.05.027_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cyto.2008.07.006","article-title":"Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42\/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells","volume":"44","author":"Park","year":"2008","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.intimp.2014.05.027_bb0125","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/aps.2009.138","article-title":"SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-kappaB pathways in RAW 264.7 macrophages","volume":"30","author":"Wang","year":"2009","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.intimp.2014.05.027_bb0130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1074\/jbc.R300030200","article-title":"Inhibitors of cytokine signal transduction","volume":"279","author":"Wormald","year":"2004","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.intimp.2014.05.027_bb0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0753-3322(02)00256-1","article-title":"Polyunsaturated fatty acids and inflammatory diseases","volume":"56","author":"Gil","year":"2002","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1568010054022024","article-title":"Macrophages in inflammation","volume":"4","author":"Fujiwara","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0022-3565(25)21307-6","article-title":"Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein\/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function","volume":"279","author":"Badger","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.intimp.2014.05.027_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S","article-title":"Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis","volume":"43","author":"Badger","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1016\/j.intimp.2014.05.027_bb0155","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1096\/fj.04-1642fje","article-title":"Inhibition of p38 MAP kinase- and RICK\/NF-kappaB-signaling suppresses inflammatory bowel disease","volume":"18","author":"Hollenbach","year":"2004","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.intimp.2014.05.027_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jnr.10671","article-title":"Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult","volume":"73","author":"Piao","year":"2003","journal-title":"J Neurosci Res"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF03401550","article-title":"An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality","volume":"1","author":"Bianchi","year":"1995","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.intimp.2014.05.027_bb0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.1999.00750.x","article-title":"Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats","volume":"115","author":"Kerlund","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"2\u20133","key":"10.1016\/j.intimp.2014.05.027_bb0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0162-3109(00)00206-X","article-title":"Inhibition of p38 MAP kinase as a therapeutic strategy","volume":"47","author":"Lee","year":"2000","journal-title":"Immunopharmacology"},{"issue":"3","key":"10.1016\/j.intimp.2014.05.027_bb0180","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/07853890600551037","article-title":"Targeting the ERK signaling pathway in cancer therapy","volume":"38","author":"Kohno","year":"2006","journal-title":"Ann Med"},{"key":"10.1016\/j.intimp.2014.05.027_bb0185","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1038\/bcj.2013.63","article-title":"A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases","volume":"3","author":"Hayakawa","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.intimp.2014.05.027_bb0190","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator DIZE ameliorates endotoxin-induced uveitis in mice","author":"Qiu","year":"2014","journal-title":"IOVS"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:57:04Z","timestamp":1746251824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1567576914002070"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.05.027","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminazene aceturate (Berenil), a new use for an old compound?","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}